{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:24:04Z","timestamp":1795029844174,"version":"4.10.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lanepe.2022.100510","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:57:54Z","timestamp":1663941474000},"page":"100510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"special_numbering":"C","title":["Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: A retrospective, population-based study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8705-7581","authenticated-orcid":false,"given":"Benjamin E.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandiah","family":"Chandrakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gincy","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaventhan","family":"Srirajaskanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2022.100510_bib0001","article-title":"Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"10.1016\/j.lanepe.2022.100510_bib0003","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.seminoncol.2018.07.001","article-title":"Epidemiologic trends in neuroendocrine tumors: an examination of incidence rates and survival of specific patient subgroups over the past 20 years","volume":"45","author":"Sackstein","year":"2018","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101598","article-title":"Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia","volume":"63","author":"Wyld","year":"2019","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"10.1016\/j.lanepe.2022.100510_bib0006","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer [Internet]"},{"issue":"3","key":"10.1016\/j.lanepe.2022.100510_bib0007","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bjs.10034","article-title":"Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria","volume":"103","author":"Sandvik","year":"2016","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062487","article-title":"The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100510_bib0010","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1038\/s41598-021-86839-2","article-title":"An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.lanepe.2022.100510_bib0011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000\u20132009: multicenter study","volume":"44","author":"Cho","year":"2012","journal-title":"Cancer Res Treat"},{"issue":"47","key":"10.1016\/j.lanepe.2022.100510_bib0012","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.3748\/wjg.v19.i47.9012","article-title":"Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany","volume":"19","author":"Scher\u00fcbl","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/EJE-12-0418","article-title":"Epidemiology of malignant digestive neuroendocrine tumours","volume":"168","author":"Lepage","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0014","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6412-8","article-title":"Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources","volume":"19","author":"Darb\u00e0","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100510_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-5057-3","article-title":"Delays and routes to diagnosis of neuroendocrine tumours","volume":"18","author":"Basuroy","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lanepe.2022.100510_bib0016","first-page":"254","article-title":"Patient perspectives, from diagnosis through treatments and beyond","volume":"18","author":"Bouvier","year":"2021","journal-title":"Elsevier"},{"issue":"11","key":"10.1016\/j.lanepe.2022.100510_bib0017","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41416-019-0606-3","article-title":"Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013\u20132015","volume":"121","author":"Genus","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100510_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1457496919874484","article-title":"Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops","volume":"110","author":"Eriksson","year":"2021","journal-title":"Scand J Surg"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100510_bib0019","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/00365521.2015.1033454","article-title":"Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors","volume":"50","author":"Kjaer","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100510_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz076","article-title":"Data resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0021","unstructured":"NCIN. Collecting and using data. Online. [cited 2022 Jan 24]. Available from: http:\/\/www.ncin.org.uk\/collecting_and_using_data\/"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0023","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lanepe.2022.100510_bib0024","series-title":"TNM Classification of Malignant Tumours","year":"2016"},{"key":"10.1016\/j.lanepe.2022.100510_bib0025","series-title":"International Classification of Diseases for Oncology (ICD-O)","author":"Fritz","year":"2013"},{"issue":"2","key":"10.1016\/j.lanepe.2022.100510_bib0026","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.lanepe.2022.100510_bib0027","unstructured":"NCIN. National Cancer Intelligence Network: Cancer survival in England by stage. [cited 2022 Jan 24]. Available from:https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/347275\/Cancer_survival_in_England_by_stage_report_.pdf"},{"issue":"Suppl 5","key":"10.1016\/j.lanepe.2022.100510_bib0028","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/annonc\/mdg750","article-title":"The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies","volume":"14","author":"Berrino","year":"2003","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"12","key":"10.1016\/j.lanepe.2022.100510_bib0029","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0030","series-title":"Non-Melanoma Skin Cancer Incidence in England 1995-2018","year":"2021"},{"issue":"2","key":"10.1016\/j.lanepe.2022.100510_bib0031","first-page":"601","article-title":"Neuroendocrine neoplasms of the appendix: a review of the literature","volume":"38","author":"Moris","year":"2018","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.lanepe.2022.100510_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.12.017","article-title":"Incidence trends of gastroenteropancreatic neuroendocrine tumors in the United States","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2022.100510_bib0033","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.2147\/CMAR.S174907","article-title":"Prognosis of patients with neuroendocrine tumor: a SEER database analysis","volume":"10","author":"Man","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"7","key":"10.1016\/j.lanepe.2022.100510_bib0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","article-title":"Sex differences in cancer incidence and survival: a pan-cancer analysis","volume":"29","author":"Dong","year":"2020","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"12","key":"10.1016\/j.lanepe.2022.100510_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052457","article-title":"Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry Data, 2005\u20132009","volume":"7","author":"Jung","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.lanepe.2022.100510_bib0036","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6604571","article-title":"Cancer survival in England and Wales at the end of the 20th century","volume":"99","author":"Rachet","year":"2008","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100510_bib0037","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100510_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.lanepe.2022.100510_bib0039","series-title":"Cancer Prevalence in England","year":"2021"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622200206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622200206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:55:38Z","timestamp":1763009738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622200206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":39,"alternative-id":["S266677622200206X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100510","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: A retrospective, population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100510"}}